Global Pet NSAIDs Market Research Report 2023(Status and Outlook)
Report Overview
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Bosson Research’s latest report provides a deep insight into the global Pet NSAIDs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pet NSAIDs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pet NSAIDs market in any manner.
Global Pet NSAIDs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal
Market Segmentation (by Type)
Carprofen
Deracoxib
Firocoxib
Meloxicam
Market Segmentation (by Application)
Dog
Cat
Horse
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pet NSAIDs Market
Overview of the regional outlook of the Pet NSAIDs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pet NSAIDs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Bosson Research’s latest report provides a deep insight into the global Pet NSAIDs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pet NSAIDs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pet NSAIDs market in any manner.
Global Pet NSAIDs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal
Market Segmentation (by Type)
Carprofen
Deracoxib
Firocoxib
Meloxicam
Market Segmentation (by Application)
Dog
Cat
Horse
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pet NSAIDs Market
Overview of the regional outlook of the Pet NSAIDs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pet NSAIDs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pet NSAIDs
1.2 Key Market Segments
1.2.1 Pet NSAIDs Segment by Type
1.2.2 Pet NSAIDs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PET NSAIDS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pet NSAIDs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Pet NSAIDs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PET NSAIDS MARKET COMPETITIVE LANDSCAPE
3.1 Global Pet NSAIDs Sales by Manufacturers (2018-2023)
3.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2018-2023)
3.3 Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pet NSAIDs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pet NSAIDs Sales Sites, Area Served, Product Type
3.6 Pet NSAIDs Market Competitive Situation and Trends
3.6.1 Pet NSAIDs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pet NSAIDs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PET NSAIDS INDUSTRY CHAIN ANALYSIS
4.1 Pet NSAIDs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PET NSAIDS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PET NSAIDS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pet NSAIDs Sales Market Share by Type (2018-2023)
6.3 Global Pet NSAIDs Market Size Market Share by Type (2018-2023)
6.4 Global Pet NSAIDs Price by Type (2018-2023)
7 PET NSAIDS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pet NSAIDs Market Sales by Application (2018-2023)
7.3 Global Pet NSAIDs Market Size (M USD) by Application (2018-2023)
7.4 Global Pet NSAIDs Sales Growth Rate by Application (2018-2023)
8 PET NSAIDS MARKET SEGMENTATION BY REGION
8.1 Global Pet NSAIDs Sales by Region
8.1.1 Global Pet NSAIDs Sales by Region
8.1.2 Global Pet NSAIDs Sales Market Share by Region
8.2 North America
8.2.1 North America Pet NSAIDs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pet NSAIDs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pet NSAIDs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pet NSAIDs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pet NSAIDs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Zoetis
9.1.1 Zoetis Pet NSAIDs Basic Information
9.1.2 Zoetis Pet NSAIDs Product Overview
9.1.3 Zoetis Pet NSAIDs Product Market Performance
9.1.4 Zoetis Business Overview
9.1.5 Zoetis Pet NSAIDs SWOT Analysis
9.1.6 Zoetis Recent Developments
9.2 Elanco
9.2.1 Elanco Pet NSAIDs Basic Information
9.2.2 Elanco Pet NSAIDs Product Overview
9.2.3 Elanco Pet NSAIDs Product Market Performance
9.2.4 Elanco Business Overview
9.2.5 Elanco Pet NSAIDs SWOT Analysis
9.2.6 Elanco Recent Developments
9.3 PREVICOX
9.3.1 PREVICOX Pet NSAIDs Basic Information
9.3.2 PREVICOX Pet NSAIDs Product Overview
9.3.3 PREVICOX Pet NSAIDs Product Market Performance
9.3.4 PREVICOX Business Overview
9.3.5 PREVICOX Pet NSAIDs SWOT Analysis
9.3.6 PREVICOX Recent Developments
9.4 Metacam
9.4.1 Metacam Pet NSAIDs Basic Information
9.4.2 Metacam Pet NSAIDs Product Overview
9.4.3 Metacam Pet NSAIDs Product Market Performance
9.4.4 Metacam Business Overview
9.4.5 Metacam Pet NSAIDs SWOT Analysis
9.4.6 Metacam Recent Developments
9.5 Chanelle Pharma
9.5.1 Chanelle Pharma Pet NSAIDs Basic Information
9.5.2 Chanelle Pharma Pet NSAIDs Product Overview
9.5.3 Chanelle Pharma Pet NSAIDs Product Market Performance
9.5.4 Chanelle Pharma Business Overview
9.5.5 Chanelle Pharma Pet NSAIDs SWOT Analysis
9.5.6 Chanelle Pharma Recent Developments
9.6 AVENTIX
9.6.1 AVENTIX Pet NSAIDs Basic Information
9.6.2 AVENTIX Pet NSAIDs Product Overview
9.6.3 AVENTIX Pet NSAIDs Product Market Performance
9.6.4 AVENTIX Business Overview
9.6.5 AVENTIX Recent Developments
9.7 Woodruff
9.7.1 Woodruff Pet NSAIDs Basic Information
9.7.2 Woodruff Pet NSAIDs Product Overview
9.7.3 Woodruff Pet NSAIDs Product Market Performance
9.7.4 Woodruff Business Overview
9.7.5 Woodruff Recent Developments
9.8 KRKA UK Ltd
9.8.1 KRKA UK Ltd Pet NSAIDs Basic Information
9.8.2 KRKA UK Ltd Pet NSAIDs Product Overview
9.8.3 KRKA UK Ltd Pet NSAIDs Product Market Performance
9.8.4 KRKA UK Ltd Business Overview
9.8.5 KRKA UK Ltd Recent Developments
9.9 Dechra
9.9.1 Dechra Pet NSAIDs Basic Information
9.9.2 Dechra Pet NSAIDs Product Overview
9.9.3 Dechra Pet NSAIDs Product Market Performance
9.9.4 Dechra Business Overview
9.9.5 Dechra Recent Developments
9.10 Parnell
9.10.1 Parnell Pet NSAIDs Basic Information
9.10.2 Parnell Pet NSAIDs Product Overview
9.10.3 Parnell Pet NSAIDs Product Market Performance
9.10.4 Parnell Business Overview
9.10.5 Parnell Recent Developments
9.11 VetUK
9.11.1 VetUK Pet NSAIDs Basic Information
9.11.2 VetUK Pet NSAIDs Product Overview
9.11.3 VetUK Pet NSAIDs Product Market Performance
9.11.4 VetUK Business Overview
9.11.5 VetUK Recent Developments
9.12 Norbrook
9.12.1 Norbrook Pet NSAIDs Basic Information
9.12.2 Norbrook Pet NSAIDs Product Overview
9.12.3 Norbrook Pet NSAIDs Product Market Performance
9.12.4 Norbrook Business Overview
9.12.5 Norbrook Recent Developments
9.13 Alivira Animal Health
9.13.1 Alivira Animal Health Pet NSAIDs Basic Information
9.13.2 Alivira Animal Health Pet NSAIDs Product Overview
9.13.3 Alivira Animal Health Pet NSAIDs Product Market Performance
9.13.4 Alivira Animal Health Business Overview
9.13.5 Alivira Animal Health Recent Developments
9.14 Vedco Inc
9.14.1 Vedco Inc Pet NSAIDs Basic Information
9.14.2 Vedco Inc Pet NSAIDs Product Overview
9.14.3 Vedco Inc Pet NSAIDs Product Market Performance
9.14.4 Vedco Inc Business Overview
9.14.5 Vedco Inc Recent Developments
9.15 Vethical
9.15.1 Vethical Pet NSAIDs Basic Information
9.15.2 Vethical Pet NSAIDs Product Overview
9.15.3 Vethical Pet NSAIDs Product Market Performance
9.15.4 Vethical Business Overview
9.15.5 Vethical Recent Developments
9.16 Vetoquinol
9.16.1 Vetoquinol Pet NSAIDs Basic Information
9.16.2 Vetoquinol Pet NSAIDs Product Overview
9.16.3 Vetoquinol Pet NSAIDs Product Market Performance
9.16.4 Vetoquinol Business Overview
9.16.5 Vetoquinol Recent Developments
9.17 Pivetal
9.17.1 Pivetal Pet NSAIDs Basic Information
9.17.2 Pivetal Pet NSAIDs Product Overview
9.17.3 Pivetal Pet NSAIDs Product Market Performance
9.17.4 Pivetal Business Overview
9.17.5 Pivetal Recent Developments
10 PET NSAIDS MARKET FORECAST BY REGION
10.1 Global Pet NSAIDs Market Size Forecast
10.2 Global Pet NSAIDs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pet NSAIDs Market Size Forecast by Country
10.2.3 Asia Pacific Pet NSAIDs Market Size Forecast by Region
10.2.4 South America Pet NSAIDs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pet NSAIDs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Pet NSAIDs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Pet NSAIDs by Type (2024-2029)
11.1.2 Global Pet NSAIDs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Pet NSAIDs by Type (2024-2029)
11.2 Global Pet NSAIDs Market Forecast by Application (2024-2029)
11.2.1 Global Pet NSAIDs Sales (K MT) Forecast by Application
11.2.2 Global Pet NSAIDs Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pet NSAIDs
1.2 Key Market Segments
1.2.1 Pet NSAIDs Segment by Type
1.2.2 Pet NSAIDs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PET NSAIDS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pet NSAIDs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Pet NSAIDs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PET NSAIDS MARKET COMPETITIVE LANDSCAPE
3.1 Global Pet NSAIDs Sales by Manufacturers (2018-2023)
3.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2018-2023)
3.3 Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pet NSAIDs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Pet NSAIDs Sales Sites, Area Served, Product Type
3.6 Pet NSAIDs Market Competitive Situation and Trends
3.6.1 Pet NSAIDs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pet NSAIDs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PET NSAIDS INDUSTRY CHAIN ANALYSIS
4.1 Pet NSAIDs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PET NSAIDS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PET NSAIDS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pet NSAIDs Sales Market Share by Type (2018-2023)
6.3 Global Pet NSAIDs Market Size Market Share by Type (2018-2023)
6.4 Global Pet NSAIDs Price by Type (2018-2023)
7 PET NSAIDS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pet NSAIDs Market Sales by Application (2018-2023)
7.3 Global Pet NSAIDs Market Size (M USD) by Application (2018-2023)
7.4 Global Pet NSAIDs Sales Growth Rate by Application (2018-2023)
8 PET NSAIDS MARKET SEGMENTATION BY REGION
8.1 Global Pet NSAIDs Sales by Region
8.1.1 Global Pet NSAIDs Sales by Region
8.1.2 Global Pet NSAIDs Sales Market Share by Region
8.2 North America
8.2.1 North America Pet NSAIDs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pet NSAIDs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pet NSAIDs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pet NSAIDs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pet NSAIDs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Zoetis
9.1.1 Zoetis Pet NSAIDs Basic Information
9.1.2 Zoetis Pet NSAIDs Product Overview
9.1.3 Zoetis Pet NSAIDs Product Market Performance
9.1.4 Zoetis Business Overview
9.1.5 Zoetis Pet NSAIDs SWOT Analysis
9.1.6 Zoetis Recent Developments
9.2 Elanco
9.2.1 Elanco Pet NSAIDs Basic Information
9.2.2 Elanco Pet NSAIDs Product Overview
9.2.3 Elanco Pet NSAIDs Product Market Performance
9.2.4 Elanco Business Overview
9.2.5 Elanco Pet NSAIDs SWOT Analysis
9.2.6 Elanco Recent Developments
9.3 PREVICOX
9.3.1 PREVICOX Pet NSAIDs Basic Information
9.3.2 PREVICOX Pet NSAIDs Product Overview
9.3.3 PREVICOX Pet NSAIDs Product Market Performance
9.3.4 PREVICOX Business Overview
9.3.5 PREVICOX Pet NSAIDs SWOT Analysis
9.3.6 PREVICOX Recent Developments
9.4 Metacam
9.4.1 Metacam Pet NSAIDs Basic Information
9.4.2 Metacam Pet NSAIDs Product Overview
9.4.3 Metacam Pet NSAIDs Product Market Performance
9.4.4 Metacam Business Overview
9.4.5 Metacam Pet NSAIDs SWOT Analysis
9.4.6 Metacam Recent Developments
9.5 Chanelle Pharma
9.5.1 Chanelle Pharma Pet NSAIDs Basic Information
9.5.2 Chanelle Pharma Pet NSAIDs Product Overview
9.5.3 Chanelle Pharma Pet NSAIDs Product Market Performance
9.5.4 Chanelle Pharma Business Overview
9.5.5 Chanelle Pharma Pet NSAIDs SWOT Analysis
9.5.6 Chanelle Pharma Recent Developments
9.6 AVENTIX
9.6.1 AVENTIX Pet NSAIDs Basic Information
9.6.2 AVENTIX Pet NSAIDs Product Overview
9.6.3 AVENTIX Pet NSAIDs Product Market Performance
9.6.4 AVENTIX Business Overview
9.6.5 AVENTIX Recent Developments
9.7 Woodruff
9.7.1 Woodruff Pet NSAIDs Basic Information
9.7.2 Woodruff Pet NSAIDs Product Overview
9.7.3 Woodruff Pet NSAIDs Product Market Performance
9.7.4 Woodruff Business Overview
9.7.5 Woodruff Recent Developments
9.8 KRKA UK Ltd
9.8.1 KRKA UK Ltd Pet NSAIDs Basic Information
9.8.2 KRKA UK Ltd Pet NSAIDs Product Overview
9.8.3 KRKA UK Ltd Pet NSAIDs Product Market Performance
9.8.4 KRKA UK Ltd Business Overview
9.8.5 KRKA UK Ltd Recent Developments
9.9 Dechra
9.9.1 Dechra Pet NSAIDs Basic Information
9.9.2 Dechra Pet NSAIDs Product Overview
9.9.3 Dechra Pet NSAIDs Product Market Performance
9.9.4 Dechra Business Overview
9.9.5 Dechra Recent Developments
9.10 Parnell
9.10.1 Parnell Pet NSAIDs Basic Information
9.10.2 Parnell Pet NSAIDs Product Overview
9.10.3 Parnell Pet NSAIDs Product Market Performance
9.10.4 Parnell Business Overview
9.10.5 Parnell Recent Developments
9.11 VetUK
9.11.1 VetUK Pet NSAIDs Basic Information
9.11.2 VetUK Pet NSAIDs Product Overview
9.11.3 VetUK Pet NSAIDs Product Market Performance
9.11.4 VetUK Business Overview
9.11.5 VetUK Recent Developments
9.12 Norbrook
9.12.1 Norbrook Pet NSAIDs Basic Information
9.12.2 Norbrook Pet NSAIDs Product Overview
9.12.3 Norbrook Pet NSAIDs Product Market Performance
9.12.4 Norbrook Business Overview
9.12.5 Norbrook Recent Developments
9.13 Alivira Animal Health
9.13.1 Alivira Animal Health Pet NSAIDs Basic Information
9.13.2 Alivira Animal Health Pet NSAIDs Product Overview
9.13.3 Alivira Animal Health Pet NSAIDs Product Market Performance
9.13.4 Alivira Animal Health Business Overview
9.13.5 Alivira Animal Health Recent Developments
9.14 Vedco Inc
9.14.1 Vedco Inc Pet NSAIDs Basic Information
9.14.2 Vedco Inc Pet NSAIDs Product Overview
9.14.3 Vedco Inc Pet NSAIDs Product Market Performance
9.14.4 Vedco Inc Business Overview
9.14.5 Vedco Inc Recent Developments
9.15 Vethical
9.15.1 Vethical Pet NSAIDs Basic Information
9.15.2 Vethical Pet NSAIDs Product Overview
9.15.3 Vethical Pet NSAIDs Product Market Performance
9.15.4 Vethical Business Overview
9.15.5 Vethical Recent Developments
9.16 Vetoquinol
9.16.1 Vetoquinol Pet NSAIDs Basic Information
9.16.2 Vetoquinol Pet NSAIDs Product Overview
9.16.3 Vetoquinol Pet NSAIDs Product Market Performance
9.16.4 Vetoquinol Business Overview
9.16.5 Vetoquinol Recent Developments
9.17 Pivetal
9.17.1 Pivetal Pet NSAIDs Basic Information
9.17.2 Pivetal Pet NSAIDs Product Overview
9.17.3 Pivetal Pet NSAIDs Product Market Performance
9.17.4 Pivetal Business Overview
9.17.5 Pivetal Recent Developments
10 PET NSAIDS MARKET FORECAST BY REGION
10.1 Global Pet NSAIDs Market Size Forecast
10.2 Global Pet NSAIDs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pet NSAIDs Market Size Forecast by Country
10.2.3 Asia Pacific Pet NSAIDs Market Size Forecast by Region
10.2.4 South America Pet NSAIDs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pet NSAIDs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Pet NSAIDs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Pet NSAIDs by Type (2024-2029)
11.1.2 Global Pet NSAIDs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Pet NSAIDs by Type (2024-2029)
11.2 Global Pet NSAIDs Market Forecast by Application (2024-2029)
11.2.1 Global Pet NSAIDs Sales (K MT) Forecast by Application
11.2.2 Global Pet NSAIDs Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pet NSAIDs Market Size Comparison by Region (M USD)
Table 5. Global Pet NSAIDs Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Pet NSAIDs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pet NSAIDs Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Pet NSAIDs Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2022)
Table 10. Global Market Pet NSAIDs Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Pet NSAIDs Sales Sites and Area Served
Table 12. Manufacturers Pet NSAIDs Product Type
Table 13. Global Pet NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pet NSAIDs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pet NSAIDs Market Challenges
Table 22. Market Restraints
Table 23. Global Pet NSAIDs Sales by Type (K MT)
Table 24. Global Pet NSAIDs Market Size by Type (M USD)
Table 25. Global Pet NSAIDs Sales (K MT) by Type (2018-2023)
Table 26. Global Pet NSAIDs Sales Market Share by Type (2018-2023)
Table 27. Global Pet NSAIDs Market Size (M USD) by Type (2018-2023)
Table 28. Global Pet NSAIDs Market Size Share by Type (2018-2023)
Table 29. Global Pet NSAIDs Price (USD/MT) by Type (2018-2023)
Table 30. Global Pet NSAIDs Sales (K MT) by Application
Table 31. Global Pet NSAIDs Market Size by Application
Table 32. Global Pet NSAIDs Sales by Application (2018-2023) & (K MT)
Table 33. Global Pet NSAIDs Sales Market Share by Application (2018-2023)
Table 34. Global Pet NSAIDs Sales by Application (2018-2023) & (M USD)
Table 35. Global Pet NSAIDs Market Share by Application (2018-2023)
Table 36. Global Pet NSAIDs Sales Growth Rate by Application (2018-2023)
Table 37. Global Pet NSAIDs Sales by Region (2018-2023) & (K MT)
Table 38. Global Pet NSAIDs Sales Market Share by Region (2018-2023)
Table 39. North America Pet NSAIDs Sales by Country (2018-2023) & (K MT)
Table 40. Europe Pet NSAIDs Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Pet NSAIDs Sales by Region (2018-2023) & (K MT)
Table 42. South America Pet NSAIDs Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Pet NSAIDs Sales by Region (2018-2023) & (K MT)
Table 44. Zoetis Pet NSAIDs Basic Information
Table 45. Zoetis Pet NSAIDs Product Overview
Table 46. Zoetis Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Zoetis Business Overview
Table 48. Zoetis Pet NSAIDs SWOT Analysis
Table 49. Zoetis Recent Developments
Table 50. Elanco Pet NSAIDs Basic Information
Table 51. Elanco Pet NSAIDs Product Overview
Table 52. Elanco Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Elanco Business Overview
Table 54. Elanco Pet NSAIDs SWOT Analysis
Table 55. Elanco Recent Developments
Table 56. PREVICOX Pet NSAIDs Basic Information
Table 57. PREVICOX Pet NSAIDs Product Overview
Table 58. PREVICOX Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. PREVICOX Business Overview
Table 60. PREVICOX Pet NSAIDs SWOT Analysis
Table 61. PREVICOX Recent Developments
Table 62. Metacam Pet NSAIDs Basic Information
Table 63. Metacam Pet NSAIDs Product Overview
Table 64. Metacam Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Metacam Business Overview
Table 66. Metacam Pet NSAIDs SWOT Analysis
Table 67. Metacam Recent Developments
Table 68. Chanelle Pharma Pet NSAIDs Basic Information
Table 69. Chanelle Pharma Pet NSAIDs Product Overview
Table 70. Chanelle Pharma Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Chanelle Pharma Business Overview
Table 72. Chanelle Pharma Pet NSAIDs SWOT Analysis
Table 73. Chanelle Pharma Recent Developments
Table 74. AVENTIX Pet NSAIDs Basic Information
Table 75. AVENTIX Pet NSAIDs Product Overview
Table 76. AVENTIX Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. AVENTIX Business Overview
Table 78. AVENTIX Recent Developments
Table 79. Woodruff Pet NSAIDs Basic Information
Table 80. Woodruff Pet NSAIDs Product Overview
Table 81. Woodruff Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Woodruff Business Overview
Table 83. Woodruff Recent Developments
Table 84. KRKA UK Ltd Pet NSAIDs Basic Information
Table 85. KRKA UK Ltd Pet NSAIDs Product Overview
Table 86. KRKA UK Ltd Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. KRKA UK Ltd Business Overview
Table 88. KRKA UK Ltd Recent Developments
Table 89. Dechra Pet NSAIDs Basic Information
Table 90. Dechra Pet NSAIDs Product Overview
Table 91. Dechra Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Dechra Business Overview
Table 93. Dechra Recent Developments
Table 94. Parnell Pet NSAIDs Basic Information
Table 95. Parnell Pet NSAIDs Product Overview
Table 96. Parnell Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Parnell Business Overview
Table 98. Parnell Recent Developments
Table 99. VetUK Pet NSAIDs Basic Information
Table 100. VetUK Pet NSAIDs Product Overview
Table 101. VetUK Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. VetUK Business Overview
Table 103. VetUK Recent Developments
Table 104. Norbrook Pet NSAIDs Basic Information
Table 105. Norbrook Pet NSAIDs Product Overview
Table 106. Norbrook Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Norbrook Business Overview
Table 108. Norbrook Recent Developments
Table 109. Alivira Animal Health Pet NSAIDs Basic Information
Table 110. Alivira Animal Health Pet NSAIDs Product Overview
Table 111. Alivira Animal Health Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Alivira Animal Health Business Overview
Table 113. Alivira Animal Health Recent Developments
Table 114. Vedco Inc Pet NSAIDs Basic Information
Table 115. Vedco Inc Pet NSAIDs Product Overview
Table 116. Vedco Inc Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Vedco Inc Business Overview
Table 118. Vedco Inc Recent Developments
Table 119. Vethical Pet NSAIDs Basic Information
Table 120. Vethical Pet NSAIDs Product Overview
Table 121. Vethical Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Vethical Business Overview
Table 123. Vethical Recent Developments
Table 124. Vetoquinol Pet NSAIDs Basic Information
Table 125. Vetoquinol Pet NSAIDs Product Overview
Table 126. Vetoquinol Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Vetoquinol Business Overview
Table 128. Vetoquinol Recent Developments
Table 129. Pivetal Pet NSAIDs Basic Information
Table 130. Pivetal Pet NSAIDs Product Overview
Table 131. Pivetal Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Pivetal Business Overview
Table 133. Pivetal Recent Developments
Table 134. Global Pet NSAIDs Sales Forecast by Region (2024-2029) & (K MT)
Table 135. Global Pet NSAIDs Market Size Forecast by Region (2024-2029) & (M USD)
Table 136. North America Pet NSAIDs Sales Forecast by Country (2024-2029) & (K MT)
Table 137. North America Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 138. Europe Pet NSAIDs Sales Forecast by Country (2024-2029) & (K MT)
Table 139. Europe Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 140. Asia Pacific Pet NSAIDs Sales Forecast by Region (2024-2029) & (K MT)
Table 141. Asia Pacific Pet NSAIDs Market Size Forecast by Region (2024-2029) & (M USD)
Table 142. South America Pet NSAIDs Sales Forecast by Country (2024-2029) & (K MT)
Table 143. South America Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 144. Middle East and Africa Pet NSAIDs Consumption Forecast by Country (2024-2029) & (Units)
Table 145. Middle East and Africa Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 146. Global Pet NSAIDs Sales Forecast by Type (2024-2029) & (K MT)
Table 147. Global Pet NSAIDs Market Size Forecast by Type (2024-2029) & (M USD)
Table 148. Global Pet NSAIDs Price Forecast by Type (2024-2029) & (USD/MT)
Table 149. Global Pet NSAIDs Sales (K MT) Forecast by Application (2024-2029)
Table 150. Global Pet NSAIDs Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pet NSAIDs Market Size Comparison by Region (M USD)
Table 5. Global Pet NSAIDs Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Pet NSAIDs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Pet NSAIDs Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Pet NSAIDs Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2022)
Table 10. Global Market Pet NSAIDs Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Pet NSAIDs Sales Sites and Area Served
Table 12. Manufacturers Pet NSAIDs Product Type
Table 13. Global Pet NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pet NSAIDs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pet NSAIDs Market Challenges
Table 22. Market Restraints
Table 23. Global Pet NSAIDs Sales by Type (K MT)
Table 24. Global Pet NSAIDs Market Size by Type (M USD)
Table 25. Global Pet NSAIDs Sales (K MT) by Type (2018-2023)
Table 26. Global Pet NSAIDs Sales Market Share by Type (2018-2023)
Table 27. Global Pet NSAIDs Market Size (M USD) by Type (2018-2023)
Table 28. Global Pet NSAIDs Market Size Share by Type (2018-2023)
Table 29. Global Pet NSAIDs Price (USD/MT) by Type (2018-2023)
Table 30. Global Pet NSAIDs Sales (K MT) by Application
Table 31. Global Pet NSAIDs Market Size by Application
Table 32. Global Pet NSAIDs Sales by Application (2018-2023) & (K MT)
Table 33. Global Pet NSAIDs Sales Market Share by Application (2018-2023)
Table 34. Global Pet NSAIDs Sales by Application (2018-2023) & (M USD)
Table 35. Global Pet NSAIDs Market Share by Application (2018-2023)
Table 36. Global Pet NSAIDs Sales Growth Rate by Application (2018-2023)
Table 37. Global Pet NSAIDs Sales by Region (2018-2023) & (K MT)
Table 38. Global Pet NSAIDs Sales Market Share by Region (2018-2023)
Table 39. North America Pet NSAIDs Sales by Country (2018-2023) & (K MT)
Table 40. Europe Pet NSAIDs Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Pet NSAIDs Sales by Region (2018-2023) & (K MT)
Table 42. South America Pet NSAIDs Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Pet NSAIDs Sales by Region (2018-2023) & (K MT)
Table 44. Zoetis Pet NSAIDs Basic Information
Table 45. Zoetis Pet NSAIDs Product Overview
Table 46. Zoetis Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Zoetis Business Overview
Table 48. Zoetis Pet NSAIDs SWOT Analysis
Table 49. Zoetis Recent Developments
Table 50. Elanco Pet NSAIDs Basic Information
Table 51. Elanco Pet NSAIDs Product Overview
Table 52. Elanco Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Elanco Business Overview
Table 54. Elanco Pet NSAIDs SWOT Analysis
Table 55. Elanco Recent Developments
Table 56. PREVICOX Pet NSAIDs Basic Information
Table 57. PREVICOX Pet NSAIDs Product Overview
Table 58. PREVICOX Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. PREVICOX Business Overview
Table 60. PREVICOX Pet NSAIDs SWOT Analysis
Table 61. PREVICOX Recent Developments
Table 62. Metacam Pet NSAIDs Basic Information
Table 63. Metacam Pet NSAIDs Product Overview
Table 64. Metacam Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Metacam Business Overview
Table 66. Metacam Pet NSAIDs SWOT Analysis
Table 67. Metacam Recent Developments
Table 68. Chanelle Pharma Pet NSAIDs Basic Information
Table 69. Chanelle Pharma Pet NSAIDs Product Overview
Table 70. Chanelle Pharma Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Chanelle Pharma Business Overview
Table 72. Chanelle Pharma Pet NSAIDs SWOT Analysis
Table 73. Chanelle Pharma Recent Developments
Table 74. AVENTIX Pet NSAIDs Basic Information
Table 75. AVENTIX Pet NSAIDs Product Overview
Table 76. AVENTIX Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. AVENTIX Business Overview
Table 78. AVENTIX Recent Developments
Table 79. Woodruff Pet NSAIDs Basic Information
Table 80. Woodruff Pet NSAIDs Product Overview
Table 81. Woodruff Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Woodruff Business Overview
Table 83. Woodruff Recent Developments
Table 84. KRKA UK Ltd Pet NSAIDs Basic Information
Table 85. KRKA UK Ltd Pet NSAIDs Product Overview
Table 86. KRKA UK Ltd Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. KRKA UK Ltd Business Overview
Table 88. KRKA UK Ltd Recent Developments
Table 89. Dechra Pet NSAIDs Basic Information
Table 90. Dechra Pet NSAIDs Product Overview
Table 91. Dechra Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Dechra Business Overview
Table 93. Dechra Recent Developments
Table 94. Parnell Pet NSAIDs Basic Information
Table 95. Parnell Pet NSAIDs Product Overview
Table 96. Parnell Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Parnell Business Overview
Table 98. Parnell Recent Developments
Table 99. VetUK Pet NSAIDs Basic Information
Table 100. VetUK Pet NSAIDs Product Overview
Table 101. VetUK Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. VetUK Business Overview
Table 103. VetUK Recent Developments
Table 104. Norbrook Pet NSAIDs Basic Information
Table 105. Norbrook Pet NSAIDs Product Overview
Table 106. Norbrook Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Norbrook Business Overview
Table 108. Norbrook Recent Developments
Table 109. Alivira Animal Health Pet NSAIDs Basic Information
Table 110. Alivira Animal Health Pet NSAIDs Product Overview
Table 111. Alivira Animal Health Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Alivira Animal Health Business Overview
Table 113. Alivira Animal Health Recent Developments
Table 114. Vedco Inc Pet NSAIDs Basic Information
Table 115. Vedco Inc Pet NSAIDs Product Overview
Table 116. Vedco Inc Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Vedco Inc Business Overview
Table 118. Vedco Inc Recent Developments
Table 119. Vethical Pet NSAIDs Basic Information
Table 120. Vethical Pet NSAIDs Product Overview
Table 121. Vethical Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Vethical Business Overview
Table 123. Vethical Recent Developments
Table 124. Vetoquinol Pet NSAIDs Basic Information
Table 125. Vetoquinol Pet NSAIDs Product Overview
Table 126. Vetoquinol Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Vetoquinol Business Overview
Table 128. Vetoquinol Recent Developments
Table 129. Pivetal Pet NSAIDs Basic Information
Table 130. Pivetal Pet NSAIDs Product Overview
Table 131. Pivetal Pet NSAIDs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Pivetal Business Overview
Table 133. Pivetal Recent Developments
Table 134. Global Pet NSAIDs Sales Forecast by Region (2024-2029) & (K MT)
Table 135. Global Pet NSAIDs Market Size Forecast by Region (2024-2029) & (M USD)
Table 136. North America Pet NSAIDs Sales Forecast by Country (2024-2029) & (K MT)
Table 137. North America Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 138. Europe Pet NSAIDs Sales Forecast by Country (2024-2029) & (K MT)
Table 139. Europe Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 140. Asia Pacific Pet NSAIDs Sales Forecast by Region (2024-2029) & (K MT)
Table 141. Asia Pacific Pet NSAIDs Market Size Forecast by Region (2024-2029) & (M USD)
Table 142. South America Pet NSAIDs Sales Forecast by Country (2024-2029) & (K MT)
Table 143. South America Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 144. Middle East and Africa Pet NSAIDs Consumption Forecast by Country (2024-2029) & (Units)
Table 145. Middle East and Africa Pet NSAIDs Market Size Forecast by Country (2024-2029) & (M USD)
Table 146. Global Pet NSAIDs Sales Forecast by Type (2024-2029) & (K MT)
Table 147. Global Pet NSAIDs Market Size Forecast by Type (2024-2029) & (M USD)
Table 148. Global Pet NSAIDs Price Forecast by Type (2024-2029) & (USD/MT)
Table 149. Global Pet NSAIDs Sales (K MT) Forecast by Application (2024-2029)
Table 150. Global Pet NSAIDs Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pet NSAIDs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pet NSAIDs Market Size (M USD), 2018-2029
Figure 5. Global Pet NSAIDs Market Size (M USD) (2018-2029)
Figure 6. Global Pet NSAIDs Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pet NSAIDs Market Size by Country (M USD)
Figure 11. Pet NSAIDs Sales Share by Manufacturers in 2022
Figure 12. Global Pet NSAIDs Revenue Share by Manufacturers in 2022
Figure 13. Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Pet NSAIDs Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pet NSAIDs Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pet NSAIDs Market Share by Type
Figure 18. Sales Market Share of Pet NSAIDs by Type (2018-2023)
Figure 19. Sales Market Share of Pet NSAIDs by Type in 2022
Figure 20. Market Size Share of Pet NSAIDs by Type (2018-2023)
Figure 21. Market Size Market Share of Pet NSAIDs by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pet NSAIDs Market Share by Application
Figure 24. Global Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 25. Global Pet NSAIDs Sales Market Share by Application in 2022
Figure 26. Global Pet NSAIDs Market Share by Application (2018-2023)
Figure 27. Global Pet NSAIDs Market Share by Application in 2022
Figure 28. Global Pet NSAIDs Sales Growth Rate by Application (2018-2023)
Figure 29. Global Pet NSAIDs Sales Market Share by Region (2018-2023)
Figure 30. North America Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Pet NSAIDs Sales Market Share by Country in 2022
Figure 32. U.S. Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Pet NSAIDs Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Pet NSAIDs Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Pet NSAIDs Sales Market Share by Country in 2022
Figure 37. Germany Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Pet NSAIDs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Pet NSAIDs Sales Market Share by Region in 2022
Figure 44. China Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Pet NSAIDs Sales and Growth Rate (K MT)
Figure 50. South America Pet NSAIDs Sales Market Share by Country in 2022
Figure 51. Brazil Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Pet NSAIDs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Pet NSAIDs Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Pet NSAIDs Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Pet NSAIDs Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Pet NSAIDs Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Pet NSAIDs Market Share Forecast by Type (2024-2029)
Figure 65. Global Pet NSAIDs Sales Forecast by Application (2024-2029)
Figure 66. Global Pet NSAIDs Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Pet NSAIDs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pet NSAIDs Market Size (M USD), 2018-2029
Figure 5. Global Pet NSAIDs Market Size (M USD) (2018-2029)
Figure 6. Global Pet NSAIDs Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pet NSAIDs Market Size by Country (M USD)
Figure 11. Pet NSAIDs Sales Share by Manufacturers in 2022
Figure 12. Global Pet NSAIDs Revenue Share by Manufacturers in 2022
Figure 13. Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Pet NSAIDs Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pet NSAIDs Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pet NSAIDs Market Share by Type
Figure 18. Sales Market Share of Pet NSAIDs by Type (2018-2023)
Figure 19. Sales Market Share of Pet NSAIDs by Type in 2022
Figure 20. Market Size Share of Pet NSAIDs by Type (2018-2023)
Figure 21. Market Size Market Share of Pet NSAIDs by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pet NSAIDs Market Share by Application
Figure 24. Global Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 25. Global Pet NSAIDs Sales Market Share by Application in 2022
Figure 26. Global Pet NSAIDs Market Share by Application (2018-2023)
Figure 27. Global Pet NSAIDs Market Share by Application in 2022
Figure 28. Global Pet NSAIDs Sales Growth Rate by Application (2018-2023)
Figure 29. Global Pet NSAIDs Sales Market Share by Region (2018-2023)
Figure 30. North America Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Pet NSAIDs Sales Market Share by Country in 2022
Figure 32. U.S. Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Pet NSAIDs Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Pet NSAIDs Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Pet NSAIDs Sales Market Share by Country in 2022
Figure 37. Germany Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Pet NSAIDs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Pet NSAIDs Sales Market Share by Region in 2022
Figure 44. China Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Pet NSAIDs Sales and Growth Rate (K MT)
Figure 50. South America Pet NSAIDs Sales Market Share by Country in 2022
Figure 51. Brazil Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Pet NSAIDs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Pet NSAIDs Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Pet NSAIDs Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Pet NSAIDs Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Pet NSAIDs Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Pet NSAIDs Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Pet NSAIDs Market Share Forecast by Type (2024-2029)
Figure 65. Global Pet NSAIDs Sales Forecast by Application (2024-2029)
Figure 66. Global Pet NSAIDs Market Share Forecast by Application (2024-2029)
